Back to Search
Start Over
Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission.
- Source :
-
Blood [Blood] 2019 Jul 04; Vol. 134 (1), pp. 85-89. Date of Electronic Publication: 2019 Apr 09. - Publication Year :
- 2019
- Subjects :
- Antineoplastic Agents therapeutic use
Fusion Proteins, bcr-abl genetics
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Protein Kinase Inhibitors therapeutic use
Remission Induction
Algorithms
Fusion Proteins, bcr-abl analysis
Genetic Testing standards
Leukemia, Myelogenous, Chronic, BCR-ABL Positive diagnosis
Neoplasm Recurrence, Local diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1528-0020
- Volume :
- 134
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Report
- Accession number :
- 30967368
- Full Text :
- https://doi.org/10.1182/blood.2019000120